End-to-End BLA Strategy for Biologics, Vaccines & Advanced Therapies
December 16, 2025
For developers of Biologics, Vaccines, and Advanced therapies, achieving FDA approval requires more than compelling science, it demands a comprehensive, audit-ready BLA strategy. From clinical development through manufacturing, quality systems,